CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $23,649,000 | +149.6% | 457,772 | +19.8% | 0.01% | +166.7% |
| Q2 2022 | $9,473,000 | +2.8% | 382,244 | +4.0% | 0.00% | 0.0% |
| Q1 2022 | $9,219,000 | -29.5% | 367,699 | +2.4% | 0.00% | -25.0% |
| Q4 2021 | $13,073,000 | +134.2% | 359,046 | +10.0% | 0.00% | +100.0% |
| Q3 2021 | $5,583,000 | +18.1% | 326,433 | -7.6% | 0.00% | 0.0% |
| Q2 2021 | $4,729,000 | -75.4% | 353,138 | -5.7% | 0.00% | -71.4% |
| Q1 2021 | $19,198,000 | -15.2% | 374,668 | +2.5% | 0.01% | -22.2% |
| Q4 2020 | $22,639,000 | +13.5% | 365,604 | +0.5% | 0.01% | 0.0% |
| Q3 2020 | $19,945,000 | +204.8% | 363,954 | +220.1% | 0.01% | +200.0% |
| Q2 2020 | $6,543,000 | +58.0% | 113,695 | +10.3% | 0.00% | +50.0% |
| Q1 2020 | $4,142,000 | +4.4% | 103,083 | +2.8% | 0.00% | 0.0% |
| Q4 2019 | $3,968,000 | +504.9% | 100,310 | +3.7% | 0.00% | – |
| Q3 2019 | $656,000 | -50.5% | 96,694 | -32.2% | 0.00% | -100.0% |
| Q2 2019 | $1,326,000 | +93.9% | 142,562 | +189.9% | 0.00% | – |
| Q1 2019 | $684,000 | +27.4% | 49,177 | 0.0% | 0.00% | – |
| Q4 2018 | $537,000 | -13.7% | 49,177 | 0.0% | 0.00% | – |
| Q3 2018 | $622,000 | -4.0% | 49,177 | 0.0% | 0.00% | – |
| Q2 2018 | $648,000 | +10.4% | 49,177 | +14.1% | 0.00% | – |
| Q1 2018 | $587,000 | +179.5% | 43,100 | +22.4% | 0.00% | – |
| Q4 2017 | $210,000 | -19.8% | 35,200 | 0.0% | 0.00% | – |
| Q3 2017 | $262,000 | -51.7% | 35,200 | -39.1% | 0.00% | -100.0% |
| Q2 2017 | $542,000 | +132.6% | 57,800 | +80.6% | 0.00% | – |
| Q1 2017 | $233,000 | -1.7% | 32,000 | 0.0% | 0.00% | – |
| Q4 2016 | $237,000 | +22.2% | 32,000 | 0.0% | 0.00% | – |
| Q3 2016 | $194,000 | +34.7% | 32,000 | 0.0% | 0.00% | – |
| Q2 2016 | $144,000 | +63.6% | 32,000 | -8.6% | 0.00% | – |
| Q1 2016 | $88,000 | -69.0% | 35,000 | 0.0% | 0.00% | – |
| Q4 2015 | $284,000 | +34.0% | 35,000 | 0.0% | 0.00% | – |
| Q3 2015 | $212,000 | -26.6% | 35,000 | 0.0% | 0.00% | – |
| Q2 2015 | $289,000 | +9.1% | 35,000 | 0.0% | 0.00% | – |
| Q1 2015 | $265,000 | +10.4% | 35,000 | 0.0% | 0.00% | – |
| Q4 2014 | $240,000 | +51.9% | 35,000 | 0.0% | 0.00% | – |
| Q3 2014 | $158,000 | -47.5% | 35,000 | -31.8% | 0.00% | -100.0% |
| Q2 2014 | $301,000 | -12.2% | 51,339 | -0.7% | 0.00% | 0.0% |
| Q1 2014 | $343,000 | +17.5% | 51,675 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $292,000 | +9.0% | 50,415 | +3.1% | 0.00% | 0.0% |
| Q3 2013 | $268,000 | -60.1% | 48,903 | +4.3% | 0.00% | 0.0% |
| Q2 2013 | $671,000 | – | 46,866 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |